Big Gain For Cyclo Therapeutics Inc.

Fri, Feb 07, 2025 at 07:39 PM

Cyclo Therapeutics Inc. (CYTH:NASDAQ) shot up at $1.19, a gain of 54.5%. On Fri, Feb 07, 2025, CYTH:NASDAQ hit a New 2-Week High of $1.19. The stock appeared on our News Catalysts scanner on Fri, Feb 07, 2025 at 08:35 AM in the 'BIOTECH' category. From Fri, Jan 24, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days

About Cyclo Therapeutics Inc. (CYTH:NASDAQ)

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease.

Top 10 Gainers:

MGO Global Inc. (MGOL:NASDAQ), 124.32%
Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 83.87%
Garden Stage Limited (GSIW:NASDAQ), 78.3%
Cyclo Therapeutics Inc. (CYTH:NASDAQ), 54.55%
Hauchen AI Parking Management Technology Holding Co. Ltd. (HCAI:NASDAQ), 36.17%
Doximity Inc. Class A (DOCS:NYSE), 35.99%
Lightbridge Corporation (LTBR:NASDAQ), 35.38%
Yoshiharu Global Co. (YOSH:NASDAQ), 34.22%
Centrus Energy Corp. (LEU:NYSEMKT), 33.13%
Prestige Wealth Inc. (PWM:NASDAQ), 28.32%